U.S. Pharmaceuticals & Biotech Undervalued Small Caps

Abeona Therapeutics

Market Cap: US$326.0m

A commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States.

Zevra Therapeutics

Market Cap: US$768.5m

A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.

Collegium Pharmaceutical

Market Cap: US$1.2b

A specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management.

ANI Pharmaceuticals

Market Cap: US$1.8b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.